ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 87221 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 87221; 2) Community: the network communities that were significantly associated with the response to NSC 87221; 3) Molecule: the relationships between components within communities and NSC 87221; 4) MDR: the compounds that were significantly associated with the NSC 87221.

NSC Compound Enrichment Correlation
NSC 129794 Ethanesulfonic acid, compd. with 2-chloro-5-[4-[m-(4,6-diamino-2,2-dimethyl-s-triazin-1(2H)-yl)phenyl]butyl]benzenesulfonyl fluoride (1:1) 0.0297837393005856 0.51362685
NSC 163424 4-Quinazolinamine, 2-[2-(1-pyrrolidinylazo)phenyl]- 0.0297837393005856 0.24577288
NSC 173552 L-Aspartic acid, N-[4-[[(2-amino-4-hydroxy-6-quinazolinyl)methyl]amino]benzoyl]-, monohydrate 0.0297837393005856 0.27328297
NSC 244404 Null 0.0297837393005856 0.18507315
NSC 254665 JUSTICIDIN B 0.0297837393005856 0.16096824
NSC 300289 Pinafide 0.0297837393005856 0.15917292
NSC 303861 L-Cysteine analog 0.0297837393005856 0.35433892
NSC 30915 Null 0.0297837393005856 0.14529025
NSC 33570 Null 0.0297837393005856 0.060153699
NSC 363813 Platinum, tetrachloro(1,2-cyclohexanediamine-N,N')-, [OC-6-22-(1S-trans)]- 0.0297837393005856 0.32103874
Total:85  Current:55    [First] [Prev] [Next] [Last]